Major relief to patients: Cardiac stents to cost 75% less now
Advertisement
Advertisement
Major life-saving devices cannot be used to earn profit. The National Pharmaceutical Pricing Authority on February 14 slashed stent prices by over 75%. Including VAT, drug eluting stents (DES) and bioresorbable vascular scaffolds (BVS) will now only cost heart patients Rs 31,080, while bare metal stents (BMS) would cost Rs 7,623.Earlier private hospitals were earning major profits from these stents. The decision is expected to break the nexus between manufacturers, doctors and hospitals that have led to "unethical" markups in the prices of these stents, according to The Economic Times.
"In short, the Authority noted that there is no value addition or financial stakes in trade at the level of hospitals and that maximum price distortion and hike takes place at that level," NPPA chairman Bhupendra Singh told ET. "Legally as well as ethically, hospitals cannot and should not charge margins," he added.
According to data from the drug pricing regulator, hospitals were found earning exorbitant margins on stents-over 650% in some cases.
Advertisement
Advertisement
- I quit McKinsey after 1.5 years. I was making over $200k but my mental health was shattered.
- Some Tesla factory workers realized they were laid off when security scanned their badges and sent them back on shuttles, sources say
- I tutor the children of some of Dubai's richest people. One of them paid me $3,000 to do his homework.
- Why are so many elite coaches moving to Western countries?
- Global GDP to face a 19% decline by 2050 due to climate change, study projects
- 5 things to keep in mind before taking a personal loan
- Markets face heavy fluctuations; settle lower taking downtrend to 4th day
- Move over Bollywood, audio shows are starting to enter the coveted ‘100 Crores Club’